Portland, OR -- (SBWIRE) -- 07/27/2017 -- Implantable drug delivery devices are the medical devices, which enable site specific drug administration. It also helps in minimizing the doses of drug in order to reduce potential side effects. These devices facilitate sustained release of a therapeutic agent. These implantable devices are gaining edge over conventional oral or parenteral dosage forms due to site specific and sustained release therapeutic action of implantable devices, which further minimize the side-effects associated with the drug.

Get full summary of the Report: https://www.alliedmarketresearch.com/implantable-drug-delivery-devices-market

Competitive Analysis

Bayer Healthcare, Boston Scientific Corporation, Allergan Inc., Medtronic Inc., Merck, Bausch and Lomb, Inc. and Abbott laboratories are some of the major players in this market. Product launch, merger & acquisition and research & development are the competitive strategies adopted by these key players. In 2013, Bayer Healthcare launched a noval hormonal intrauterine device (IUD) Skyla. The same product is launched in Europe with the brand name Jaydess, which is used for the prevention of pregnancy for up to three years.

HIGH-LEVEL ANALYSIS

According to Porter's Five Forces analysis, the bargaining power of the supplier is high as products are highly differentiated. High switching cost leads to the low bargaining power of buyers. Threat from substitutes is low due to presence of fewer substitutes in the market. Many competitors are present in the market with high exit barriers, which lead to tough competition. Threat of new entrants is low as brand names are well known and profitability requires economies of scale. SWOT analysis helps in determining the internal and external environmental factors for strategic business planning. Study of key players and their strategies help in developing market entry and expansion strategy.

Request Sample Report: https://www.alliedmarketresearch.com/request-toc-and-sample/449

MARKET BY PRODUCT TYPE

- Implantable Coronary Drug Eluting Stents
- Implantable Bio-Absorbable Stents
- Implantable Contraceptive Drug Delivery Devices
- Implantable Intraocular Drug Delivery Devices
- Implantable Brachytherapy Seeds
- Implantable Drug Infusion Pumps

MARKET BY TECHNOLOGY

- Biodegradable Implantable Drug Delivery Device Technology
- Non-Biodegradable Implantable Drug Delivery Device Technology

MARKET BY APPLICATION

- Ophthalmology
- Cardiovascular
- Birth Control/Contraception
- Oncology
- Others

MARKET BY GEOGRAPHY

- North America
- Europe
- Asia-Pacific
- LAMEA